0001183740-13-000257.txt : 20130711
0001183740-13-000257.hdr.sgml : 20130711
20130711121744
ACCESSION NUMBER: 0001183740-13-000257
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20130711
DATE AS OF CHANGE: 20130711
EFFECTIVENESS DATE: 20130711
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: EUPRAXIA PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001581178
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-199419
FILM NUMBER: 13963391
BUSINESS ADDRESS:
STREET 1: 1240-666 BURRARD STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 2X8
BUSINESS PHONE: 604-685-0088
MAIL ADDRESS:
STREET 1: 1240-666 BURRARD STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 2X8
D
1
primary_doc.xml
X0706
D
LIVE
0001581178
EUPRAXIA PHARMACEUTICALS INC.
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
604-685-0088
BRITISH COLUMBIA, CANADA
Plaza Capital Partners Inc.
None
Corporation
true
2012
DAVID
STADNYK
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Director
JAMES
HELLIWELL
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Executive Officer
Director
JOHN
MONTALBANO
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Director
SIMON
PIMSTONE
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Director
PAUL
GEYER
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Director
MICHAEL
WILMINK
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Director
GEORGE
TSAFALAS
1240-666 BURRARD STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
V6C 2X8
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06
false
2012-08-31
false
true
false
0
10139
10139
0
13(a) represents the price of the shares (1,000,000 shares @ C$0.01), converted to US$ based on the exchange rate on the date of issuance, August 31, 2012, of US$1.00=C$0.9863.
false
1
0
0
0
false
EUPRAXIA PHARMACEUTICALS INC.
/s/ George Tsafalas
George Tsafalas
Chief Financial Officer
2013-07-09